Bottom Line Up Front: VA rates gout under Diagnostic Code 5017 — but how it gets rated changed dramatically on February 7, 2021. Under the old criteria, gout was rated like rheumatoid arthritis based on how many incapacitating flares you had per year (20–100%). Under the new criteria, gout is rated based on limitation of motion of each affected joint using joint-specific codes. Here is the part most veterans miss: VA must apply whichever system gives you the higher rating. That dual-track comparison is the single most underutilized strategy in gout claims. And if your gout affects multiple joints, each joint gets its own separate rating.

In This Guide

The Dual-Track Rating System (Old vs. New Criteria)

Before February 7, 2021, VA rated gout under DC 5017 by cross-referencing it to DC 5002 — the code for multi-joint arthritis rated as an “active process.” That system counted how many incapacitating exacerbations you had per year and assigned a rating accordingly.

On February 7, 2021, VA finalized a musculoskeletal rating overhaul (85 FR 76453). Under the new criteria, gout is evaluated as degenerative arthritis based on limitation of motion of the affected joints, using joint-specific diagnostic codes like DC 5271 for the ankle or DC 5260/5261 for the knee.

The strategy most veterans miss: Under 38 U.S.C. § 5110(g), for any claim filed or pending during or after February 7, 2021, the VA must apply both the old and new criteria and give you whichever produces the higher rating. BVA Decisions 22018223 (March 2022) and 22069608 (December 2022) both confirm the VA performs this dual-track analysis. If your rating decision only applied one set of criteria, you may have grounds for a Higher-Level Review.

This matters more than you might think. A veteran whose gout is controlled by allopurinol (fewer than 3 flares per year) would max out at 20% under the old criteria — but if that veteran has permanent joint restriction from prior gout damage, the new ROM-based criteria could yield a higher rating. Conversely, a veteran with frequent severe flares but relatively preserved joint motion between attacks may fare better under the old criteria.

Track 1: Old Criteria — DC 5002 Active Process Ratings

Under the old criteria, gout was rated based on the frequency of incapacitating exacerbations:

Rating Criteria (Old — DC 5002 Active Process)
100% Constitutional manifestations associated with active joint involvement, totally incapacitating
60% Less than totally incapacitating, with weight loss and anemia productive of severe impairment of health or severely incapacitating exacerbations occurring 4 or more times a year, or a lesser number over prolonged periods
40% Symptom combinations productive of definite impairment of health objectively supported by examination findings or incapacitating exacerbations occurring 3 or more times a year
20% One or two exacerbations a year in a well-established diagnosis
Critical definition: An “incapacitating exacerbation” is not just a bad flare. BVA Decision 22069608 confirmed that the term means “a period of acute signs and symptoms that require bed rest prescribed by a physician and treatment by a physician.” This definition comes from DC 5243 (intervertebral disc syndrome). If your doctor told you to “take it easy” but did not explicitly prescribe bed rest, the VA may not count that episode. Make sure your doctor’s notes use the words “prescribed bed rest.”

For veterans with uncontrolled gout — frequent severe attacks despite medication — these old criteria can produce ratings of 40% to 60% that would be difficult to achieve under ROM-based criteria alone.

Track 2: New Criteria — ROM-Based Joint Ratings

Under the new criteria (effective February 7, 2021), the Note to DCs 5013–5024 directs that gout (DC 5017) be evaluated “as degenerative arthritis, based on limitation of motion of affected parts.” This means the VA measures your range of motion at each joint affected by gout and assigns a rating using the joint-specific diagnostic code.

Ankle Gout Ratings (DC 5271)

Rating Ankle Limitation of Motion
20% Marked limitation of motion
10% Moderate limitation of motion

Knee Gout Ratings (DC 5260 — Limited Flexion)

Rating Knee Flexion Limited To
30% 15 degrees
20% 30 degrees
10% 45 degrees
0% 60 degrees

Knee Gout Ratings (DC 5261 — Limited Extension)

Rating Knee Extension Limited To
50% 45 degrees
40% 30 degrees
30% 20 degrees
20% 15 degrees
10% 10 degrees
0% 5 degrees
Important: DC 5003’s X-ray-only backup criteria (the 10%/20% for degenerative changes visible on X-ray without compensable ROM loss) do not apply to gout. The Note to DC 5003 specifically excludes conditions under DCs 5013–5024 from the X-ray rubric. If your rating decision applied DC 5003 X-ray criteria to your gout, that is a coding error worth challenging through a Higher-Level Review.

The new criteria are particularly advantageous for veterans whose gout is medication-controlled (fewer flares) but who have permanent joint damage from years of urate crystal deposits. Under the old system, controlled gout with few flares caps at 20%. Under the new system, the permanent ROM restriction can yield higher ratings regardless of current flare frequency.

Multi-Joint Gout: Separate Ratings for Each Joint

This is one of the most valuable findings in our review of BVA decisions. A veteran with gout affecting multiple joints can receive a separate disability rating for each joint.

BVA Decision 1204989 (2012) confirmed that VA granted separate disability evaluations for each joint affected by service-connected gout. Under the new ROM-based criteria, this means:

Key strategy: For the knee, if both flexion (DC 5260) and extension (DC 5261) are limited by gout, you can receive two separate ratings for the same knee. This is one of the rare exceptions to the pyramiding prohibition. VA Knowledge Base confirms this dual-rating approach for knee conditions.

These ratings combine using VA math (not simple addition). But a veteran with bilateral ankle gout (20% each) plus bilateral knee gout (10% each for limited flexion) could reach a combined rating well above what a single “gout” rating would produce.

Do not file a single claim for “gout.” File separate claims for each affected joint: “gout of the right ankle,” “gout of the left knee,” and so on. This ensures each joint is evaluated and rated independently.

The Great Toe Problem: DC 5284 Does NOT Apply to Gout

The first metatarsophalangeal (MTP) joint — the big toe — is the most common site for gout attacks. You might expect the VA to rate severe great toe gout under DC 5284 (“Foot injuries, other”), which offers ratings of 10%, 20%, 30%, or 40%. But it cannot.

BVA Decision 21069446 (2021), citing the CAVC ruling in Yancy v. McDonald, confirmed that DC 5284 applies only to actual injuries to the foot — not degenerative conditions. Gout is a degenerative metabolic condition, not an injury, so DC 5284 is off the table.

This creates a genuine rating gap for great toe gout. There is no great-toe-specific ROM code comparable to DC 5260/5261 for the knee or DC 5271 for the ankle. The hallux valgus (DC 5280) and hallux rigidus (DC 5281) codes cap at 10% and are the wrong codes for gout anyway.

Strategic workaround: If your gout primarily affects the big toe, focus your claim on ankle ROM limitation. During a gout attack at the MTP joint, the adjacent tibiotalar joint (ankle) is frequently affected as well. Document the ankle restriction — this opens up DC 5271 (10–20%) or, in severe cases with ankylosis, DC 5270 (20–40%). The ankle is where the higher ratings live, not the toe.

Tophaceous Gout and the Ankylosis Pathway

Veterans with longstanding gout (typically 10+ years) who have developed tophi — hard deposits of uric acid crystite under the skin and in joints — have access to the highest possible musculoskeletal ratings through the ankylosis pathway.

Medical literature confirms that chronic tophaceous gout causes “destructive deforming arthritis, extensive bone destruction, and severe deformities.” When tophi destroy enough of the joint structure, the joint becomes ankylosed (fused or immobile).

Code Joint Rating Range
DC 5270 Ankle ankylosis 20–40%
DC 5256 Knee ankylosis 30–60%

BVA Decision 1645141 (2016) documented a veteran with “advanced gout and complications thereof, including widespread tophi of feet and hands” whose physician stated he was “crippled with severe gout” and “totally disabled.”

If you have tophi: Request imaging specifically to document joint destruction. X-rays showing “punched-out” erosions, dual-energy CT (DECT) showing urate crystal deposition, and documentation of joint deformity are critical. The C&P examiner must document evidence of joint destruction and deformity, not just measure ROM.

How to Establish Service Connection for Gout

Direct Service Connection

To establish direct service connection, you need:

  1. An in-service event, injury, or onset of symptoms (documented in service treatment records)
  2. A current diagnosis of gout
  3. A medical nexus linking the current diagnosis to service

Common in-service triggers include military diet (high-purine MREs and field rations), dehydration from deployments, medications prescribed during service that elevate uric acid, and kidney issues documented during service.

Secondary Service Connection

Secondary service connection is often the stronger path. These are the established secondary pathways with BVA precedent or strong medical support:

Secondary Conditions FROM Gout

Once gout is service-connected, you can claim conditions caused by your gout. These downstream secondary claims are frequently overlooked and can be worth more than the gout rating itself.

Chronic Kidney Disease (DC 7502)

This is the highest-value secondary condition from gout. Chronic gout causes uric acid nephropathy, which damages the kidneys over time. BVA Decision 1726064 (2017) confirmed a veteran receiving 60% for gout and 60% for CKD simultaneously.

CKD ratings under DC 7502 can reach 100%. If you have service-connected gout and any decline in renal function (elevated creatinine, reduced GFR), file a secondary claim for CKD immediately.

Other Secondary Conditions

Claiming Gout Secondary to Other Conditions

The secondary service connection pathways described above deserve a closer look because they involve legal frameworks that most veterans and even many VSO representatives do not fully understand.

The Diuretic Medication Pathway (Strongest)

If you take hydrochlorothiazide, furosemide, or other diuretics for service-connected hypertension, the pathway to gout is straightforward and has direct BVA precedent (Decision 22069267). Your nexus letter should trace: service-connected hypertension → prescribed diuretic medication → elevated serum uric acid → gout diagnosis.

The Sleep Apnea Pathway

Service-connected sleep apnea causes oxygen levels to drop repeatedly during sleep (intermittent hypoxia). This triggers increased uric acid production through the purine degradation pathway. If you have service-connected sleep apnea and gout, this is a viable secondary claim. Ask your rheumatologist or internist to specifically address the hypoxia-uric acid mechanism in your nexus letter.

The PTSD Multi-Step Chains

These require more documentation but are legally supported:

Chain A — PTSD → AUD → Gout: Get a nexus letter from a psychiatrist connecting PTSD to alcohol use disorder (self-medication of PTSD symptoms), then a separate nexus letter from an internist connecting chronic alcohol use to elevated uric acid and gout. Reference Allen v. Principi (2001). The “willful misconduct” defense does not apply to substance abuse caused by a service-connected condition.
Chain B — PTSD → Obesity → Gout: Get a nexus letter connecting PTSD to obesity (compensatory eating, physical inactivity, medication side effects), then a nexus letter connecting obesity to gout (insulin resistance, metabolic syndrome, reduced uric acid clearance). Reference Larson v. McDonough (2021) and BVA Decision A25034500 (2025), which confirmed the PTSD → obesity intermediate step is actively being granted.

The Bilateral Factor

Under 38 CFR § 4.26, when you have compensable disabilities in both lower extremities (or both upper extremities), VA adds approximately 10% to the combined value of those paired ratings before combining them with your other disabilities.

For a veteran with gout rated at both the right ankle (20%) and left ankle (20%):

VA frequently misses this. The bilateral factor should be applied automatically, but check your combined rating calculation. If you have bilateral lower extremity gout ratings and the bilateral factor was not applied, file a Higher-Level Review citing 38 CFR § 4.26.

C&P Exam Tips for Gout

The C&P exam is where your claim is won or lost. Based on our review of BVA decisions and the regulatory framework, here is what matters:

1. Flare-Up Documentation Is Critical

Under DeLuca v. Brown (1995, CAVC) and Sharp v. Shulkin, the C&P examiner must assess your functional loss during flare-ups — even if you are examined during a quiescent period between attacks. The 2021 DBQ updates added explicit flare-up questions. If the examiner fails to estimate your ROM limitation during a typical gout flare, that is grounds for remand.

Do not rely on the examiner asking. Bring a written statement describing your worst flare-up in detail: how long it lasted, whether you could bear weight, whether your doctor prescribed bed rest, and what medications were required. Hand this to the examiner and ask that it be documented in the DBQ.

2. Multiple DBQs for Multiple Joints

There is no gout-specific DBQ. The examiner uses the DBQ for whatever joint is affected:

If your gout affects multiple joints, make sure the examiner completes a DBQ for each affected joint. Do not let the examiner do a single “gout exam” without measuring ROM at every affected joint individually.

3. Bring Photos and Medical Records

4. Document “Prescribed Bed Rest” Language

If you are pursuing the old DC 5002 criteria (flare-based ratings), you need your medical records to show physician-prescribed bed rest during flares. Ask your treating physician to use that specific language in their notes going forward.

5. Request Both Criteria Be Evaluated

Explicitly state in your claim submission that you are requesting the VA evaluate your gout under both the old criteria (DC 5002 active process) and the new criteria (ROM-based joint codes), applying whichever produces the higher rating per 38 U.S.C. § 5110(g).

Your Action Steps

  1. File an Intent to File (VA Form 21-0966) immediately to lock in your effective date while you gather evidence.
  2. File separate claims for each affected joint. Do not file a single “gout” claim. Specify “gout of the right ankle,” “gout of the left knee,” etc.
  3. Request the dual-track analysis in writing. State that both old DC 5002 criteria and new ROM-based criteria must be evaluated, with the more favorable applied.
  4. Get full ROM measurements at your C&P exam for every affected joint — ankle dorsiflexion/plantarflexion, knee flexion/extension, great toe MTP dorsiflexion if affected.
  5. Prepare a flare-up statement. Describe your worst attack: duration, severity, ability to bear weight, medications required, and whether bed rest was prescribed.
  6. If your gout is medication-controlled but you have permanent joint restriction, focus on the new ROM-based criteria — this is where controlled gout can still get higher ratings.
  7. If you have 3+ flares per year with physician-prescribed bed rest, focus on the old DC 5002 criteria for 40–60% ratings.
  8. File secondary claims for CKD if you have any decline in kidney function (elevated creatinine, reduced GFR).
  9. Check for secondary connection pathways — hypertension (diuretics), sleep apnea, PTSD (via AUD or obesity).
  10. If bilateral lower extremity gout: verify the bilateral factor (38 CFR § 4.26) was applied to your combined rating.
  11. If you have tophi: request imaging (X-ray, DECT) to document bone erosion and joint destruction. Push for ankylosis ratings (DC 5270 for ankle, DC 5256 for knee).
  12. Pull your rating decision coding sheet. If it shows DC 5003 as the basis for your gout rating using the X-ray-only rubric, file a Higher-Level Review — that is a coding error.

Not Sure Where to Start With Your Gout Claim?

VetAid’s AI analysis engine reviews your case documents and identifies the rating criteria, secondary conditions, and claim strategy specific to your situation.

Analyze My Case Free

Frequently Asked Questions

What is the VA rating for gout?

VA rates gout under DC 5017 using a dual-track system. Under the old criteria (DC 5002), ratings are 20%, 40%, 60%, or 100% based on incapacitating flare frequency. Under the new criteria (effective February 7, 2021), gout is rated based on limitation of motion at each affected joint. The VA must apply whichever system produces the higher rating. Additionally, each affected joint receives its own separate rating.

How does VA rate gout attacks?

Under the old DC 5002 criteria, attacks (“incapacitating exacerbations”) are the central rating factor. Three or more per year qualifies for 40%, and four or more qualifies for 60%. But the definition is strict: your doctor must explicitly prescribe bed rest during the attack, and you must receive physician treatment. Under the new criteria, attacks matter less because ratings are based on permanent ROM restriction — but documenting flare-up functional loss under DeLuca v. Brown remains critical to capturing the full severity of your condition.

Can I claim gout secondary to medication?

Yes. Diuretic medications prescribed for service-connected hypertension are known to elevate serum uric acid and trigger gout. BVA Decision 22069267 (2022) specifically granted gout secondary to hypertension through this medication pathway. You will need a nexus letter tracing the chain from your service-connected condition to the medication to elevated uric acid to gout. This is one of the strongest and most straightforward secondary gout claims.

What secondary conditions can I claim with gout?

The most significant secondary condition from gout is chronic kidney disease (CKD), which can be rated up to 100% under DC 7502. BVA Decision 1726064 confirmed 60% for gout and 60% for CKD simultaneously. Other secondary conditions include kidney stones, hypertension, osteoarthritis in affected joints, and depression/anxiety from chronic pain. Gout itself can also be claimed secondary to hypertension, sleep apnea, PTSD (via alcohol use or obesity as intermediate steps), and chronic kidney disease.

Legal References